Tower Research Capital LLC (TRC) - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 1 filers reported holding KURA ONCOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$32,604
-34.6%
3,575
-24.1%
0.00%
-50.0%
Q2 2023$49,832
+127674.4%
4,710
+46.8%
0.00%
+100.0%
Q1 2023$39
-9.3%
3,209
-8.1%
0.00%
-50.0%
Q4 2022$43
-99.9%
3,490
+54.8%
0.00%
+100.0%
Q3 2022$31,000
-78.2%
2,254
-70.9%
0.00%
-66.7%
Q2 2022$142,000
+407.1%
7,746
+341.1%
0.00%
Q1 2022$28,000
-88.8%
1,756
-90.2%
0.00%
-100.0%
Q4 2021$251,000
+23.6%
17,952
+65.3%
0.00%
-20.0%
Q3 2021$203,000
+62.4%
10,863
+82.0%
0.01%
+66.7%
Q2 2021$125,000
+5.9%
5,970
+42.7%
0.00%
+50.0%
Q1 2021$118,000
-18.6%
4,185
-5.8%
0.00%
-50.0%
Q4 2020$145,000
+68.6%
4,444
+57.6%
0.00%
+300.0%
Q3 2020$86,000
-46.9%
2,820
-71.7%
0.00%
-85.7%
Q2 2020$162,000
-2.4%
9,978
-17.1%
0.01%
-50.0%
Q4 2019$166,000
+268.9%
12,035
+305.4%
0.01%
+366.7%
Q3 2019$45,000
-59.5%
2,969
-47.6%
0.00%
-57.1%
Q2 2019$111,0005,668
+20142.9%
0.01%
Q4 2018$0
-100.0%
28
-95.5%
0.00%
-100.0%
Q3 2018$11,000
+450.0%
627
+445.2%
0.00%
Q2 2018$2,000
-71.4%
115
-68.8%
0.00%
-100.0%
Q1 2018$7,000
+250.0%
368
+170.6%
0.00%
Q3 2017$2,000
-66.7%
136
-78.6%
0.00%
-100.0%
Q2 2017$6,000
+500.0%
635
+217.5%
0.00%
Q3 2016$1,000
-96.4%
200
-98.1%
0.00%
-100.0%
Q2 2016$28,000
+460.0%
10,426
+738.1%
0.00%
+200.0%
Q1 2016$5,000
-44.4%
1,244
+21.7%
0.00%0.0%
Q4 2015$9,0001,0220.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q4 2023
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 206,307$3,363,00011.31%
Foresite Capital Management IV, LLC 1,307,982$21,320,00010.39%
EcoR1 Capital, LLC 4,608,529$75,119,0005.55%
Prosight Management, LP 685,000$11,166,0004.79%
ACUTA CAPITAL PARTNERS, LLC 872,500$14,222,0004.11%
BVF INC/IL 2,775,882$45,247,0002.79%
VR Adviser, LLC 575,000$9,373,0002.24%
ALETHEA CAPITAL MANAGEMENT, LLC 216,171$3,524,0002.06%
DAFNA Capital Management LLC 294,260$4,796,0001.38%
Vivo Capital, LLC 1,050,000$17,115,0001.23%
View complete list of KURA ONCOLOGY INC shareholders